feed,title,long_url,short_url
SeekingAlpha,Cricut: Don't See Any Catalyst For Demand To Recover,https://seekingalpha.com/article/4697294,
SeekingAlpha,All Eyes On Simufilam: Cassava Sciences' Make-Or-Break Moment,https://seekingalpha.com/article/4697293,
